Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irbesartan in HFpEF (I-Preserve)
NCT00095238Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jun 2002
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 25
01
Overview
A Phase 3 trial of irbesartan in heart failure with preserved ejection fraction (HFpEF), sponsored by Bristol Myers Squibb. Started Jun 2002; status: completed.
02
Drugs
irbesartan
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT00095238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095238.